Price
Frequently asked questions
What is PacBio's market capitalization?
What is the Earnings Per Share (EPS) for PacBio?
What are the analyst ratings and target price for PacBio's stock?
What is PacBio's revenue over the trailing twelve months?
What is the EBITDA for PacBio?
What is the free cash flow of PacBio?
What is the 5-year beta of PacBio's stock?
How many employees does PacBio have, and what sector and industry does it belong to?
What is the free float of PacBio's shares?
Financials
Market Cap
$484.74M5Y beta
1.96EPS (TTM)
-$1.456Free Float
268.75MRevenue (TTM)
$173.15MEBITDA (TTM)
-$269.82MFree Cashflow (TTM)
-$239.56MPricing
Analyst Ratings
The price target is $3.292 and the stock is covered by 15 analysts.
Buy
7
Hold
8
Sell
0
Information
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
796
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker